Bentham Science Logo

Current Topics in Medicinal Chemistry

Volume 20, 32 Issues, 2020
ISSN: 1873-4294 (Online)
ISSN: 1568-0266 (Print)
This journal supports open access

Ranking and Category

  • 20th of 61 in

    Chemistry, Medicinal

Order Your Article Before Print

Meet the Executive Guest Editor(s)

G. Aliev
President "GALLY" International Biomedical Research Consulting LLC
San Antonio, TX
USA
Dr. Gjumrakch Aliev received his MD in 1982 from the Baku Medical University (former USSR) with cum laude. Then, he accomplished his Ph.D. in Cardiovascular Diseases from the prestigious Russian Academy of the Medical Sciences, Moscow, Russia in 1989 with cum laude. He received postdoctoral training with Professor G. Burnstock at the University College of London. He authored and co-authored more than 500 publications in the fields of neurodegenerative disease research (Alzheimer's disease), as well as cardio-and cerebrovascular disease, cancer, and electron microscopy. He is an outstanding teacher, scholar, and a renowned scientist in the area of cellular.


L. Feng
WuXi PharmaTech Co., Ltd.
Wuhan
China
Dr. Lian-Shun Feng obtained his PhD degree from Tsinghua University in 2011, and then worked as postdoctorial researcher in Peking University. Currently, Dr. Lian-Shun Feng work in WuXi AppTec as principal investigator. In 2017 and 2018, around 20 peer-reviewed SCI papers were published, and many of them were cited over 100 times in two years.


B. Li
The Second Hospital of Jilin University
Changchun
China
Dr. Bingjin Li is a graduate of Yanbian University, China. She received her Ph.D. from Ehime University, Japan. She performed postdoc training at Washington State University and is a full professor at the second hospital of Jilin University, China. Her lab uses behavioral and electrophysiological analyses to explore the underlying relationship between neuronal function and behavior. This integrative approach involves the use of molecular biology, biochemistry, immunocytohistochemistry, neurophysiology, anatomy, and a wide range of behavioral methodology to understand the function of the nervous system.


X. Luo
The first affiliated hospital of Xiamen university
Fujian
China
Dr. Luo got his PhD degree and received the postdoctoral training at central south university. Then he worked as a research assistant at the Chinese university of Hong Kong. In 2017, he joined the first affiliated hospital of Xiamen university. His research interests focus on the field of clinical pharmacology, including clinical pharmacokinetics, pharmacodynamics and clinical phase I of new drugs. He has had over 10 years’ experience in the development of biomarkers in personalized medicine in a variety of disorders, such as cancer, transplantation, etc. Currently, he has responsible for more than 50 clinical phase I studies.


D.S. Stoyanov
Medical University of Plovdiv
Plovdiv
Bulgaria
Dr Drozdstoy Stoyanov holds currently the academic position of Full Professor and Head, Neuropsychiatry and Brain Imaging Group, Medical University, Plovdiv. He is Vice Chair of Philosophy SIG, Royal College of Psychiatrists, UK, Visiting Fellow in the University of Pittsburgh, USA (2009), International Distinguished Fellow of the American Psychiatric Association (2018), Guest Lecturer in the Universities of Copenhagen (2015), Vienna (2017) and Bergen (2018).He published more than 160 scholarly papers, including five monographs and three textbooks. Dr Stoyanov is Associate Editor of Frontiers in Psychiatry and the European Journal of Person Centered Health Care; Editorial Board member of Dialogues in Philosophy, Mental and Neurosciences, International Journal for Person Centered Medicine, Folia Medica and others. Ad hoc reviewer in Current Medicinal Chemistry, Molecular Neurobiology, Human Brain Mapping, Journal of Affective Disorders, Biotechnology and Biotechnological Equipement.


S.S. Thakur
Centre for Cellular and Molecular Biology
Hyderabad
India
My research interests involves application of Mass Spectrometry based proteomics in Health and Disease especially biomarker discovery and Drug Development. My group uses mass spectrometry based high throughput quantitative proteomics, natural product chemistry, cell biology, animal model, stem cell, and modern biology approach to find the target, to develop novel drugs and elucidate its mode of action against cancer and other metabolic disorders such as diabetes. Cancer is a hyperplastic condition that leads to uncontrolled proliferation, invasion, metastasis, dysregulation of apoptosis and cell cycle. Cancer is the second leading cause of worldwide human mortality after cardiovascular diseases. We are investigating the efficacy of various natural and synthetic metabolites on melanoma, retinoblastoma, leukaemia, and lung cancer using in vitro and in vivo method including animal model. Further, investigating the molecular basis for Cell adhesion, AKT signalling and tyrosine kinase associated cancer progression and response and resistance to targeted therapy in these cancers is in progress in my lab.



Editor-in-Chief

Allen B. Reitz
Fox Chase Chemical Diversity Center, Inc.
Doylestown, PA
USA

Biography View Full Editorial Board

Journal History

Current Topics in Medicinal Chemistry was introduced in 2001 with the assistance of Dr. Allen B. Reitz, who is the current Editor-in-Chief serving since 2001.
Track Your Manuscript:


Scopus CiteScore Metrics: 2.94


Related Journals

Related eBooks

eBooks Catalog